Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 541 record(s)

Req # A-2021-000509

Adverse Reaction Reports (AERs) for TUBERCULIN TEST. Report numbers: 000924327, 000929098, 000928605.

Organization: Health Canada

13 page(s)
August 2021

Req # A-2021-000515

In January 2021, interviews were conducted with NGOs and Health Care Providers as part of "an evaluation of Health Portfolio Tobacco and Vaping Activities, which includes both Health Canada and the Public Health Agency of Canada". A copy…

Organization: Health Canada

0 page(s)
August 2021

Req # A-2021-000544

Adverse Reaction Reports (AERs) for LEUPROLIDE ACETATE. Report numbers: E2B_03413381, E2B_03413387, 000926931.

Organization: Health Canada

28 page(s)
August 2021

Req # A-2021-000545

Adverse Drug Reaction (ADR) for ALIROCUMAB. Report number: E2B_03408783.

Organization: Health Canada

21 page(s)
August 2021

Req # A-2021-000550

Adverse Drug Reaction (ADR) for METOLAZONE. Report number: 000922329.

Organization: Health Canada

7 page(s)
August 2021

Req # A-2021-000553

Adverse Reaction Reports (AERs) for SARILUMAB. Report numbers: E2B_03481113, E2B_03326624.

Organization: Health Canada

196 page(s)
August 2021

Req # A-2021-000574

Adverse Drug Reaction (ADR). Report number: 000941781.

Organization: Health Canada

1 page(s)
August 2021

Req # A-2021-000577

Adverse Drug Reaction (ADR). Report number: 000947871.

Organization: Health Canada

7 page(s)
August 2021

Req # A-2021-000578

Adverse Drug Reaction (ADR). Report number: 000948466.

Organization: Health Canada

2 page(s)
August 2021

Req # A-2021-000606

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-075471-867.

Organization: Health Canada

7 page(s)
August 2021
Date modified: